Clinical Trial Update: Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol. [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of GKT137831 in patients with primary biliary cholangitis (primary biliary cirrhosis) on ursodiol; study completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cirrhosis

Drugs mentioned

• GKT137831 (setanaxib)

Snippet

Sponsor: Calliditas Therapeutics AB | Conditions: Primary Biliary Cirrhosis | Phase 2 | Status: COMPLETED | Results posted: 2022-03-31